State of the Industry 2010: Predicted pharmaceutical spending
State of the Industry survey results
The mean forecast among survey respondents is 16.8%, much higher than Dr. Barlow's prediction. Understandably, members might estimate a high percentage, she says, because of the immediate effect they feel in their wallets when filling a prescription.
"Pharmacy is the area where you pay right out of your pocket at the time of service," she says, but adds that the real focus should be on services and procedures.
The greatest increase in pharmaceutical spending will be from specialty drugs, but that could slow down as competition in that area increases. Rising pharmaceutical spending can mean less overall healthcare spending because effective drug utilization as a first-line treatment can reduce the need for costlier, more complicated treatments later.
"The more you spend on the pharmacy sector, the better off you are in terms of medical spending," she says.
Extending the Capabilities of the EHR Through Automation
August 2nd 2023Welcome back to another episode of "Tuning In to the C-Suite," where Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of chatting with Cindy Gaines, chief clinical transformation officer at Lumeon.
Listen
Merith Basey Advocates for Transparency in PBM Practices | AHIP 2024
June 11th 2024Merith Basey, M.Sc., executive director of Patients for Affordable Drugs, discusses her group's focus on the monopoly pricing of pharmaceutical companies and bills in Congress addressing patent reform and "pay for delay" strategies, in an interview with MHE previewing the presentation she's co-presenting on June 11 at the AHIP 2024 meeting in Las Vegas.
Read More
A Conversation With Greg Baker, RPh, CEO of AffirmedRx
March 31st 2024Greg Baker, CEO of AffirmedRx, describes his early career, shares some of his critical opinions about the pharmacy benefit management (PBM) industry and how, in his view, his company is offering a better alternative.
Read More
